Back to search

Belgium· BE-AMP-SAM153535-00

Diafusor 10 10,10mg/24h

A glyceryl trinitrate product containing glyceryl trinitrate, registered in Belgium by MSD Belgium. The same ATC class is registered in 14 of our 19 countries.

ATC C01DA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDiafusor 10 10,10mg/24hATCC01DA02REGISTER NO.BE-AMP-SAM153535-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Glyceryl trinitrate is registered in 14 of 19 countries.

Countries holding a registration under ATC C01DA02 (glyceryl trinitrate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Glyceryl trinitrate · ATC C01DA02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glyceryl trinitrate costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Glyceryl trinitrate · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Glyceryl Trinitrate
Manufacturer
MSD Belgium
Country
Belgium (BE)
ATC code
C01DA02
ATC class
Glyceryl trinitrate
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0306100
  • be_apb
    0739201

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

324 interactions on record for glyceryl trinitrate.

Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glyceryl trinitrate · interactions on record

324 records

  • 74 moderate
  • 22 minor
  • 223 info

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glyceryl trinitrate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glyceryl trinitrate products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Glytrin, Nitro Pohl
  • Bulgaria · Нитронал Аквас
  • Cyprus · Glyceryl Trinitrate Bristol Laboratories, Nitrong
  • Czechia · Nitro Pohl, Nitroglycerin Slovakofarma
  • Germany · Glyceroltrinitrat Carinopharm, Nitrolingual Akut
  • Denmark · Glycerylnitrat, Glytrin
  • Estonia · Nitrocine, Nitroglycerin
  • Spain · Cordiplast, Dermatrans
  • Finland · Deponit Nt, Nitroglycerin
  • France · Discotrine, Epinitril
  • United Kingdom (Northern Ireland) · Deponit, Glyceryl Trinitrate Accord- Uk
  • Greece · Nitroglicerina Acarpia, Nitrong
  • Croatia · Nitrolingual
  • Hungary · Glicerin-Trinitrát Egis, Nitromint
  • Ireland · Dermatrans, Epinitril
  • Iceland · Nitroglycerin
  • Italy · Adesitrin, Deponit
  • Lithuania · Nitrocine, Nitroglycerin
  • Luxembourg · Minitran, Rectogesic
  • Latvia · Nitrocine, Nitrocor
  • Malta · Nitrong
  • Netherlands · Deponit, Glytrin
  • Norway · Nitroglycerin, Nitroglycerin Abcur
  • Poland · Nitrocard, Nitromint
  • Portugal · Epinitril, Gtn
  • Romania · Nitroglicerină Zentiva S.A., Nitromint
  • Sweden · Glytrin, Nitroglycerin Abcur
  • Slovenia · Nitrolingual, Nitronal
  • Slovakia · Nitroglycerin Slovakofarma, Nitromint

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cfc7adc1-8085-498f-aae1-0ff2650d5fe9
GET /v1/drugs/cfc7adc1-8085-498f-aae1-0ff2650d5fe9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Transdermal patch",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Diafusor 10 10,10mg/24h",
  "name_fr": "Diafusor 10 10,10mg/24h",
  "name_nl": "Diafusor 10 10,10mg/24h",
  "amp_code": "SAM153535-00",
  "strengths": [
    "80.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Glyceryl Trinitrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Glyceryl Trinitrate",
  "authorisation_numbers": [
    "BE153535"
  ]
}

See everything about glyceryl trinitrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.